US 11786541
Inhibitor of sphingosine kinase 2 for treating Ebola
granted A61KA61K31/435A61K31/438
Quick answer
US patent 11786541 (Inhibitor of sphingosine kinase 2 for treating Ebola) held by RedHill Biopharma Ltd. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K31/4409, A61K31/7048